Antiphospholipid antibodies predict post-stroke depression after acute ischemic stroke. 2019

Guangli Wang, and Yiting Zhou, and Xiaoqing Bu, and Hao Peng, and Tan Xu, and Aili Wang, and Libing Guo, and Jiale Liu, and Jintao Zhang, and Dong Li, and Jianhui Zhang, and Zhong Ju, and Chung-Shiuan Chen, and Jing Chen, and Jiang He, and Yonghong Zhang, and Chongke Zhong
Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, 199 Renai Road, Industrial Park District, Suzhou, Jiangsu Province 215123, China.

Antiphospholipid activity was reported to be increased in depressive patients, while the impact of antiphospholipid antibodies (aPLs) on post-stroke depression (PSD) is unclear. We aimed to investigate the associations of aPLs, including antiphosphatidylserine (aPS) and anticardiolipin (aCL) antibodies with depression after acute ischemic stroke. aPS and aCL were measured in 497 ischemic stroke patients recruited from 7 of 26 participating hospitals of China Antihypertensive Trial in Acute Ischemic Stroke. 24-item Hamilton Depression Rating Scale was used to evaluate PSD status at 3 months after stroke. Compared with aPS-negative or aCL-negative, the adjusted odds ratios (ORs) [95% confidence intervals (CIs)] associated with aPS-positive or aCL-positive were 1.77 (1.07-2.92) or 2.06 (1.11-3.80) for risk of PSD. On continuous analyses, per 1-SD increment of aPS and aCL were associated with 29% (OR 1.29, 95% CI 1.06-1.58) and 30% (OR 1.30, 95% CI 1.06-1.60) increased risks for PSD, respectively. Adding aPLs to conventional risk factors models significantly improved risk reclassification for PSD (net reclassification improvement index = 21.87%, P = 0.016 for aPS; net reclassification improvement index = 32.24%, P = 0.0004 for aCL). aPLs levels were tested only at baseline without serial measurements, and we were unable to detect the association between aPLs changes and PSD. Higher aPS and aCL levels in the acute phase of ischemic stroke were associated with increased risk of 3-month PSD, suggesting that aPLs may play an important role in post-stroke depression prediction.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D002681 China A country spanning from central Asia to the Pacific Ocean. Inner Mongolia,Manchuria,People's Republic of China,Sinkiang,Mainland China
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Guangli Wang, and Yiting Zhou, and Xiaoqing Bu, and Hao Peng, and Tan Xu, and Aili Wang, and Libing Guo, and Jiale Liu, and Jintao Zhang, and Dong Li, and Jianhui Zhang, and Zhong Ju, and Chung-Shiuan Chen, and Jing Chen, and Jiang He, and Yonghong Zhang, and Chongke Zhong
January 1992, Heart disease and stroke : a journal for primary care physicians,
Guangli Wang, and Yiting Zhou, and Xiaoqing Bu, and Hao Peng, and Tan Xu, and Aili Wang, and Libing Guo, and Jiale Liu, and Jintao Zhang, and Dong Li, and Jianhui Zhang, and Zhong Ju, and Chung-Shiuan Chen, and Jing Chen, and Jiang He, and Yonghong Zhang, and Chongke Zhong
November 2021, Journal of personalized medicine,
Guangli Wang, and Yiting Zhou, and Xiaoqing Bu, and Hao Peng, and Tan Xu, and Aili Wang, and Libing Guo, and Jiale Liu, and Jintao Zhang, and Dong Li, and Jianhui Zhang, and Zhong Ju, and Chung-Shiuan Chen, and Jing Chen, and Jiang He, and Yonghong Zhang, and Chongke Zhong
April 2020, Experimental and therapeutic medicine,
Guangli Wang, and Yiting Zhou, and Xiaoqing Bu, and Hao Peng, and Tan Xu, and Aili Wang, and Libing Guo, and Jiale Liu, and Jintao Zhang, and Dong Li, and Jianhui Zhang, and Zhong Ju, and Chung-Shiuan Chen, and Jing Chen, and Jiang He, and Yonghong Zhang, and Chongke Zhong
July 2021, Journal of neurology,
Guangli Wang, and Yiting Zhou, and Xiaoqing Bu, and Hao Peng, and Tan Xu, and Aili Wang, and Libing Guo, and Jiale Liu, and Jintao Zhang, and Dong Li, and Jianhui Zhang, and Zhong Ju, and Chung-Shiuan Chen, and Jing Chen, and Jiang He, and Yonghong Zhang, and Chongke Zhong
October 2003, Neurology,
Guangli Wang, and Yiting Zhou, and Xiaoqing Bu, and Hao Peng, and Tan Xu, and Aili Wang, and Libing Guo, and Jiale Liu, and Jintao Zhang, and Dong Li, and Jianhui Zhang, and Zhong Ju, and Chung-Shiuan Chen, and Jing Chen, and Jiang He, and Yonghong Zhang, and Chongke Zhong
November 2023, Ideggyogyaszati szemle,
Guangli Wang, and Yiting Zhou, and Xiaoqing Bu, and Hao Peng, and Tan Xu, and Aili Wang, and Libing Guo, and Jiale Liu, and Jintao Zhang, and Dong Li, and Jianhui Zhang, and Zhong Ju, and Chung-Shiuan Chen, and Jing Chen, and Jiang He, and Yonghong Zhang, and Chongke Zhong
January 2019, Neuropsychiatric disease and treatment,
Guangli Wang, and Yiting Zhou, and Xiaoqing Bu, and Hao Peng, and Tan Xu, and Aili Wang, and Libing Guo, and Jiale Liu, and Jintao Zhang, and Dong Li, and Jianhui Zhang, and Zhong Ju, and Chung-Shiuan Chen, and Jing Chen, and Jiang He, and Yonghong Zhang, and Chongke Zhong
May 2019, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques,
Guangli Wang, and Yiting Zhou, and Xiaoqing Bu, and Hao Peng, and Tan Xu, and Aili Wang, and Libing Guo, and Jiale Liu, and Jintao Zhang, and Dong Li, and Jianhui Zhang, and Zhong Ju, and Chung-Shiuan Chen, and Jing Chen, and Jiang He, and Yonghong Zhang, and Chongke Zhong
January 2023, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association,
Guangli Wang, and Yiting Zhou, and Xiaoqing Bu, and Hao Peng, and Tan Xu, and Aili Wang, and Libing Guo, and Jiale Liu, and Jintao Zhang, and Dong Li, and Jianhui Zhang, and Zhong Ju, and Chung-Shiuan Chen, and Jing Chen, and Jiang He, and Yonghong Zhang, and Chongke Zhong
July 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association,
Copied contents to your clipboard!